Podcast

Pharmacy Focus: Oncology Edition - An Update on Prostate Cancer and the Growing Role of Pharmacists

As treatments improve and prostate cancer potentially becomes more of a chronic illness, pharmacists have a chance to shine.

This month, we spoke with Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, director of pharmacy cancer care services at Mayo Clinic, to learn about the latest updates and pipeline treatments in prostate cancer. As treatments improve and prostate cancer potentially becomes more of a chronic illness, Soefje said pharmacists have a chance to shine.

Related Videos
Related Content
Key Sessions and Opportunities for Pharmacists at the AACR Immunotherapy Conference
February 21st 2025

Key Sessions and Opportunities for Pharmacists at the AACR Immunotherapy Conference

Alana Hippensteele, Lead Editor
The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma
January 31st 2025

The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma

Alexandra Gerlach, Associate Editor
Chronic graft-vs-host disease -- Image credit: dizain | stock.adobe.com
February 21st 2025

New Therapy for Chronic Graft-Vs-Host Disease: Axatilimab

Grashma Vadakkel, PharmD, BCOP Melinda Cook, PharmD, BCOP Kristian Casem, PharmD, BCOP Stephen Eng, PharmD, BCOP
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
Doctor measuring waist of overweight woman in clinic, closeup - Image credit: New Africa | stock.adobe.com
February 20th 2025

Study Finds Central Obesity Measures More Accurate for Assessing Colorectal Cancer Risk Than BMI

Kennedy Ferruggia, Assistant Editor
Diffuse large B-cell lymphoma -- Image credit: LASZLO | stock.adobe.com
February 20th 2025

Current Treatment Approaches for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Jessica M. Lewis-Gonzalez, PharmD, BCOP Shashank R. Cingam, MD